Gowda R - Search Results

1

Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanoma.

Gowda R, Madhunapantula SV, Desai D, Amin S, Robertson GP. Gowda R, et al. Mol Cancer Ther. 2013 Jan;12(1):3-15. doi: 10.1158/1535-7163.MCT-12-0492. Epub 2012 Oct 30. Mol Cancer Ther. 2013. PMID: 23112250 Free PMC article.

2

Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.

Tran MA, Gowda R, Sharma A, Park EJ, Adair J, Kester M, Smith NB, Robertson GP. Tran MA, et al. Among authors: gowda r. Cancer Res. 2008 Sep 15;68(18):7638-49. doi: 10.1158/0008-5472.CAN-07-6614. Cancer Res. 2008. PMID: 18794153 Free PMC article.

3

Targeting sphingosine kinase-1 to inhibit melanoma.

Madhunapantula SV, Hengst J, Gowda R, Fox TE, Yun JK, Robertson GP. Madhunapantula SV, et al. Among authors: gowda r. Pigment Cell Melanoma Res. 2012 Mar;25(2):259-74. doi: 10.1111/j.1755-148X.2012.00970.x. Pigment Cell Melanoma Res. 2012. PMID: 22236408 Free PMC article.

4

Selenium-containing histone deacetylase inhibitors for melanoma management.

Gowda R, Madhunapantula SV, Desai D, Amin S, Robertson GP. Gowda R, et al. Cancer Biol Ther. 2012 Jul;13(9):756-65. doi: 10.4161/cbt.20558. Epub 2012 Jun 6. Cancer Biol Ther. 2012. PMID: 22669577 Free PMC article.

5

Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.

Sharma A, Madhunapantula SV, Gowda R, Berg A, Neves RI, Robertson GP. Sharma A, et al. Among authors: gowda r. Am J Pathol. 2013 Apr;182(4):1151-62. doi: 10.1016/j.ajpath.2012.12.019. Epub 2013 Feb 12. Am J Pathol. 2013. PMID: 23416158 Free PMC article.

6

Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.

Madhunapantula SV, Sharma A, Gowda R, Robertson GP. Madhunapantula SV, et al. Among authors: gowda r. Pigment Cell Melanoma Res. 2013 Nov;26(6):886-99. doi: 10.1111/pcmr.12156. Epub 2013 Sep 19. Pigment Cell Melanoma Res. 2013. PMID: 24034838 Free PMC article.

7

Targeting multiple key signaling pathways in melanoma using leelamine.

Gowda R, Madhunapantula SV, Kuzu OF, Sharma A, Robertson GP. Gowda R, et al. Mol Cancer Ther. 2014 Jul;13(7):1679-89. doi: 10.1158/1535-7163.MCT-13-0867. Epub 2014 Mar 31. Mol Cancer Ther. 2014. PMID: 24688050 Free PMC article.

8

Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport.

Kuzu OF, Gowda R, Sharma A, Robertson GP. Kuzu OF, et al. Among authors: gowda r. Mol Cancer Ther. 2014 Jul;13(7):1690-703. doi: 10.1158/1535-7163.MCT-13-0868. Epub 2014 Mar 31. Mol Cancer Ther. 2014. PMID: 24688051 Free PMC article.

9

Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma.

Gowda R, Madhunapantula SV, Sharma A, Kuzu OF, Robertson GP. Gowda R, et al. Mol Cancer Ther. 2014 Oct;13(10):2328-40. doi: 10.1158/1535-7163.MCT-14-0357. Epub 2014 Jul 31. Mol Cancer Ther. 2014. PMID: 25082958 Free PMC article.

10

Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.

Gowda R, Sharma A, Robertson GP. Gowda R, et al. Cancer Lett. 2017 Jan 28;385:243-250. doi: 10.1016/j.canlet.2016.10.016. Epub 2016 Oct 18. Cancer Lett. 2017. PMID: 27769779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters